Inflammatory cytokine removal by an activated carbon device in a flowing system

Weigand, 2004, The systemic inflammatory response syndrome, Best Practice & Research Clinical Anaesthesiology, 18, 455, 10.1016/j.bpa.2003.12.005 Robertson, 2006, The systemic inflammatory response syndrome, Microbes and Infection, 8, 1382, 10.1016/j.micinf.2005.12.016 Paparella, 2002, Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update, European Journal of Cardio-thoracic Surgery, 21, 232, 10.1016/S1010-7940(01)01099-5 Stegmayr, 2001, Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome, Therapeutic Apheresis, 5, 123, 10.1046/j.1526-0968.2001.005002123.x Sherwood, 2004, Mechanisms of the inflammatory response, Best Practice & Research Clinical Anaesthesiology, 18, 385, 10.1016/j.bpa.2003.12.002 Rodriguez-Gaspar, 2001, Prognostic value of cytokines in SIRS general medical patients, Cytokine, 15, 232, 10.1006/cyto.2001.0932 Lin, 2000, Inflammatory cytokines and cell response in surgery, Surgery, 127, 117, 10.1067/msy.2000.101584 Remick, 2003, Cytokine therapeutics for the treatment of sepsis: why has nothing worked?, Current Pharmaceutical Design, 9, 75, 10.2174/1381612033392567 Peters, 2003, Molecular basis of endothelial dysfunction in sepsis, Cardiovascular Research, 60, 49, 10.1016/S0008-6363(03)00397-3 Winchester, 2003, Sorbents in acute renal failure and the systemic inflammatory response syndrome, Blood Purification, 21, 79, 10.1159/000067860 Steczko, 1999, Cytokines and endotoxin removal by sorbents and application in push–pull sorbent-based pheresis: the Biologic-DTPF system, Artificial Organs, 23, 310, 10.1046/j.1525-1594.1999.06232.x Kellum, 2004, Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kB DNA binding, and improves short-term survival in lethal endotoxemia, Critical Care Medicine, 32, 801, 10.1097/01.CCM.0000114997.39857.69 Vincent, 2005, A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection, Shock, 23, 400, 10.1097/01.shk.0000159930.87737.8a Shoji, 2003, Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin), Therapeutic Apheresis and Dialysis, 7, 108, 10.1046/j.1526-0968.2003.00005.x Walker, 1976, Evaluation and selection of activated carbon for hemoperfusion, Kidney International, 10, S320 Oda, 2004, Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro study, Blood Purification, 22, 530, 10.1159/000082526 Mikhalovsky, 1999, Microparticles for hemoperfusion and extracorporeal therapy, vol. 2, 133 Sandeman, 2005, Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsis, Biomaterials, 26, 7124, 10.1016/j.biomaterials.2005.05.019 Howell, 2006, The in vitro adsorption of cytokines by polymer-pyrolysed carbon, Biomaterials, 27, 5286, 10.1016/j.biomaterials.2006.05.041 Steffel, 2006, Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications, Circulation, 113, 722, 10.1161/CIRCULATIONAHA.105.567297 Josic, 2003, Preparation of vitamin K dependent proteins such as clotting factors II, VII, IX and X and clotting inhibitor protein C, Journal of Chromatography B, 790, 193, 10.1016/S1570-0232(03)00082-5 Venkataraman, 2003, Clinical review: extracorporeal blood purification in severe sepsis, Critical Care, 7, 139, 10.1186/cc1889 Taniguchi, 2006, A novel adsorbent of circulating bacterial toxins and cytokines: the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia, Critical Care Medicine, 34, 800, 10.1097/01.CCM.0000202449.15027.AE